Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver Cancer

Figure 9

Enrichment plots from gene set enrichment analysis (GSEA). GSEA results showing cell cycle (a), RNA degradation (b), pathways in cancer (c), adherens junction (d), DNA replication (e), regulation of actin cytoskeleton (f), mTOR signaling pathway (g), glycerophospholipid metabolism (h), and VEGF signaling pathway (i) were differentially enriched in CEP55 high expression phenotype. NES: normalized ES; NOM value: normalized value; FDR: false discovery rate.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)